Participated · Equity · Dec 2025

Ripple Foods develops and sells dairy-free products—primarily plant-based milks, protein shakes, and half-and-half—made from yellow-pea protein that deliver up to 20 g of protein per serving while avoiding common allergens such as nuts, soy, and lactose. The products contain 50 % more calcium than dairy milk, less sugar and fewer calories, and are marketed as pediatrician-recommended and family-friendly. Available nationwide through retailers like Whole Foods, Target, Kroger, and Walmart, Ripple has achieved consistent double-digit top-line growth by capitalizing on the $23 B alternative-protein market. The company is a Certified B-Corporation and emphasizes sustainable production that uses significantly less water than dairy. With a loyal customer base, Ripple plans to launch an organic milk line in Q1 2026, deepen penetration of its core and high-protein kids’ milks, and enter food-service channels. Recently appointed CEO Becky O’Grady, a former General Mills executive and long-time Ripple board member, will lead these initiatives. The firm aims to expand distribution, drive brand visibility, and move toward profitability with the backing of its latest financing.

Participated · Equity · Nov 2025

Founded in 2020, Iambic Therapeutics integrates pioneering AI models, such as its Enchant multimodal transformer and NeuralPLexer structure predictor, with automated chemistry to run weekly design-make-test cycles. The platform is used to generate differentiated development candidates and has already delivered new drugs into human trials with what the company claims is unprecedented speed. Its lead asset, IAM1363, has shown anti-tumor activity and a favorable safety profile in HER2-wild-type and HER2-mutated cancers, and is now part of a clinical collaboration with Jazz Pharmaceuticals. Additional internal programs targeting KIF18A and CDK2/4 are expected to enter the clinic soon. Iambic is also engaged in a technology-enablement collaboration with Revolution Medicines that pairs proprietary data with NeuralPLexer capabilities. The company advances both wholly owned and partnered pipelines aimed at addressing urgent unmet needs. Backed by a recent oversubscribed financing of more than $100 million, Iambic is positioned to expand its pipeline, partnerships, and platform innovations.

Participated · Series B · Nov 2025

Elephas Biosciences has built the Elephas Live™ Platform, an ex-vivo, live-tumor-profiling system that maintains a biopsy’s native tumor micro-environment while addressing tumor heterogeneity. The platform functionally characterizes immune response in real time, enabling clinicians to better predict whether a cancer patient will benefit from immunotherapy. With only one in five patients currently responding to immunotherapy, Elephas aims to raise overall response rates and expand patient eligibility by providing more accurate predictive data. The company plans to launch the platform in 2026 as a laboratory developed test (LDT) to accelerate clinical adoption. Recent additions to its Scientific Advisory Board, including Jérôme Galon, Ph.D., and Janis Taube, M.D., signal continued scientific validation efforts. Headquartered in Madison, Wisconsin, Elephas is privately held and backed by a syndicate of life-science investors. The newly secured funding will finance commercialization activities and further technology development.

Participated · Seed · May 2025

Atlas Data Storage is developing end-to-end DNA data storage products that leverage synthetic DNA’s high density, 1,000+ year durability, and scalable, low-cost copying. Its core technology couples novel semiconductor chips with enzyme engineering to enable high-throughput, massively parallel chemistry on a chip. Atlas intends to sell data center products for hyperscalers, enterprises, and government customers to meet AI-era storage demands with ultra-high density, security, and lower power and e-waste. The company positions DNA storage as permanent archival storage that eliminates ongoing migration and reduces carbon impact. Atlas recently completed an initial seed financing and acquired DNA data storage technology assets from Twist Bioscience to accelerate commercialization. The company is led by CEO Varun Mehta, CTO Bill Banyai, and Executive Chairman George Kadifa and is based in South San Francisco, California.

Participated · Series D · Dec 2024

Amp Robotics builds AI-powered robotic sorting systems that use cameras and robotic arms to identify and pluck recyclables from conveyor belts. The company shifted its business model from placing robots in existing plants to running entire sorting facilities as a service. Amp handles operations, maintenance, and upgrades while contracting partners handle waste sourcing, offtake of valuable materials, and disposal of non-recyclables. The company charges customers per ton of waste sorted. The decade-old company has deployed around 400 robots and operates three facilities with another in the works. Amp recently raised $91M in a Series D, a round that was slightly smaller than its prior Series C, which raised $104M per SEC filings, highlighting fundraising headwinds for mid- to late-stage startups. AMP Robotics develops AI-powered robotic sorting systems (its flagship product is AMP Cortex) to pick and reclaim plastics, cardboard, paper, cans, cartons and other packaging types. The company says Cortex can perform 80 to 120 picks per minute and its AI platform has identified over 75 billion objects to date. AMP offers a more compact AMP Cortex-C and an integrated, standalone facility offering, and also resells recyclable commodities to end-market buyers. The startup employs around 200 people and reports a robotic fleet of roughly 275 units deployed in over 100 centers, with Waste Connections as its largest customer. AMP plans to grow its secondary sortation business across three U.S. production facilities in the Denver, Atlanta and Cleveland metro areas and pursue larger fleet-wide and international deployments. The company says new capital will help scale operations, retrofit existing recycling infrastructure and build technology and team capacity for upcoming opportunities. AMP Robotics develops AI-driven computer vision and high-speed robotics systems (AMP Cortex and AMP Neuron) that identify and sort recyclables from mixed material streams. Its technology recognizes materials by color, size, shape, opacity, and brand, and can recover items as small as bottlecaps or specific items like Keurig pods. AMP has hundreds of deployments across North America, Asia, and Europe and a coast-to-coast U.S. presence spanning more than 20 states, and signed its largest contract to deploy 24 systems with Waste Connections. The company will use the new funding to scale operations, develop new AI product applications for materials recovery facilities, and support market expansion with CPG partners such as Keurig Dr Pepper to help meet recycled-content goals. AMP's technology aims to improve material quality, worker safety, productivity, and reduce costs and greenhouse gas emissions while increasing recycling rates and resource recovery. Headquartered and manufactured in Colorado, AMP positions itself as the leading provider of AI-guided robotics systems for recycling globally. AMP Robotics is a Denver-based company that builds recycling robots combining computer vision, machine learning and robotic automation to improve sorting efficiency and material quality. Its systems can identify branded packaging and are used to sort plastics, cartons, fiber and metals, with deployments across multiple U.S. states. In October the company completed a 14-robot installation at Single Stream Recyclers, the largest single deployment in the recycling industry, and its robots can sort and pick about twice as fast as people with higher accuracy. AMP has two revenue streams: a robotics-as-a-service offering and a direct sales option, and it has made installations in California, Colorado, Indiana, Minnesota, New York, Pennsylvania, Texas, Virginia and Wisconsin. The company plans to use new funding to expand manufacturing capacity, broaden its market scope and push into international markets, and it is building out reporting capabilities tied to its vision systems. AMP is also exploring applications beyond recyclables, including automotive scrap and construction waste.